Celator Pharmaceuticals Inc

CIK 1327467 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Celator Pharmaceuticals Inc.

Recent SEC filings

FiledFormAccession number
Feb 13, 2018CT ORDER9999999997-18-000826
Feb 15, 2017SC 13G/A0001193125-17-045108
Feb 14, 2017SC 13G/A0000950159-17-000044
Jan 30, 2017SC 13G/A0001144204-17-004722
Aug 2, 201615-12B/A0001193125-16-668304
Aug 1, 2016EFFECT9999999995-16-005302
Jul 27, 2016POS AM0001193125-16-660294
Jul 25, 2016EFFECT9999999995-16-005223
Jul 22, 201615-12B0001193125-16-654638
Jul 15, 2016SC 13D/A0000919574-16-014203
Jul 13, 201640001192482-16-000665
Jul 12, 201625-NSE0001354457-16-000433
Jul 12, 201640000904454-16-001317
Jul 12, 201640000899243-16-024954
Jul 12, 2016S-8 POS0001193125-16-646361
Jul 12, 201640000899243-16-024958
Jul 12, 201640000899243-16-024956
Jul 12, 201640000899243-16-024952
Jul 12, 201640000899243-16-024953
Jul 12, 201640000919574-16-014070
Jul 12, 20168-K0001193125-16-646347
Jul 12, 201640000919574-16-014068
Jul 12, 2016POS AM0001193125-16-646355
Jul 12, 201640000899243-16-024948
Jul 12, 2016SC TO-T/A0001193125-16-645979